Table 1.

Patient disposition.

	Recently diagnosed patients (≤3 years)	Chronic patients (>3 years)
Patients enrolled (n)	234	361
ITT population* (n)	233	360
	↓	↓
Most common reasons for early study discontinuation (≥2% in any group) (%)
Withdrawal of consent	6.4	12.5
Lost to follow-up	3.9	2.8
Adverse event	3.4	7.8
Lack of efficacy	3.0	2.2

*Patients who received at least one dose of study drug.

ITT: Intent-to-treat.